Literature DB >> 10978655

Detection of psilocin in body fluids.

G Sticht1, H Käferstein.   

Abstract

Active compounds of some mushrooms e.g. Psilocybe cubensis, Paneolus subalteatus or Stropharia coronilla, the psychotropic agents psilocybin and psilocin, have hallucinogenic effects. In one case of 'magic mushroom' intake, we had to analyse blood and urine. Psilocin was detected in the urine with REMEDi HS. Most of the psilocin was excreted as the glucuronide. Therefore an enzymatic hydrolysis should be the first step in analysis. Free psilocin was determined at a concentration of 0.23 mg/l while the total amount was 1.76 mg/l urine. The concentration of psilocin in serum was too low for detection with REMEDi HS. We proved a GC-MS-method with d(3)-morphine as internal standard and silylation with MSTFA. Similarly to urine, most of the psilocin in serum was found in the conjugated form. The concentration of free psilocin was 0.018 mg/l, that of total psilocin, 0.052 mg/l serum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978655     DOI: 10.1016/s0379-0738(00)00213-9

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  9 in total

1.  A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability.

Authors:  Rafaela Martin; Jennifer Schürenkamp; Heidi Pfeiffer; Helga Köhler
Journal:  Int J Legal Med       Date:  2011-12-03       Impact factor: 2.686

2.  Development of a psilocin immunoassay for serum and blood samples.

Authors:  C Albers; H Köhler; M Lehr; B Brinkmann; J Beike
Journal:  Int J Legal Med       Date:  2004-08-03       Impact factor: 2.686

3.  Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.

Authors:  Anna Bravermanová; Michaela Viktorinová; Filip Tylš; Tomáš Novák; Renáta Androvičová; Jakub Korčák; Jiří Horáček; Marie Balíková; Inga Griškova-Bulanova; Dominika Danielová; Přemysl Vlček; Pavel Mohr; Martin Brunovský; Vlastimil Koudelka; Tomáš Páleníček
Journal:  Psychopharmacology (Berl)       Date:  2018-01-05       Impact factor: 4.530

4.  Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.

Authors:  Rafaela Martin; Jennifer Schürenkamp; Angela Gasse; Heidi Pfeiffer; Helga Köhler
Journal:  Int J Legal Med       Date:  2012-11-27       Impact factor: 2.686

Review 5.  Mushroom Poisoning.

Authors:  Robert Wennig; Florian Eyer; Andreas Schaper; Thomas Zilker; Hilke Andresen-Streichert
Journal:  Dtsch Arztebl Int       Date:  2020-10-16       Impact factor: 5.594

6.  Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.

Authors:  Nenad Manevski; Mika Kurkela; Camilla Höglund; Timo Mauriala; Michael H Court; Jari Yli-Kauhaluoma; Moshe Finel
Journal:  Drug Metab Dispos       Date:  2009-12-10       Impact factor: 3.922

Review 7.  Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?

Authors:  Maurizio Coppola; Francesco Bevione; Raffaella Mondola
Journal:  J Xenobiot       Date:  2022-02-07

8.  Genomic Analysis of Stropharia rugosoannulata Reveals Its Nutritional Strategy and Application Potential in Bioremediation.

Authors:  Ying Yang; Guoliang Meng; Shujun Ni; Haifeng Zhang; Caihong Dong
Journal:  J Fungi (Basel)       Date:  2022-02-06

9.  Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis.

Authors:  Anna Poliwoda; Katarzyna Zielińska; Piotr P Wieczorek
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.